Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study-Reference-Cited by-同舟云学术

Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study

Published:2021-05-03 Issue:8 Volume:23 Page:1956-1960
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Khunti Kamlesh¹^ORCID,Charbonnel Bernard²,Chen Hungta³,Cherney David Z.⁴,Cooper Andrew⁵^ORCID,Fenici Peter⁵,Gomes Marilia B.⁶^ORCID,Hammar Niklas⁷⁸,Heerspink Hiddo J. L.⁹^ORCID,Ji Linong¹⁰^ORCID,Medina Jesús¹¹,Nicolucci Antonio¹²^ORCID,Ramirez Larisa¹³^ORCID,Rathmann Wolfgang¹⁴,Shestakova Marina V.¹⁵^ORCID,Shimomura Iichiro¹⁶,Tang Fengming¹⁷,Watada Hirotaka¹⁸^ORCID,Kosiborod Mikhail¹⁷¹⁹²⁰,

Affiliation:

1. Diabetes Research Centre University of Leicester Leicester UK

2. Faculty of Medicine University of Nantes Nantes France

3. AstraZeneca Gaithersburg Maryland USA

4. University Health Network University of Toronto Toronto Ontario Canada

5. AstraZeneca Cambridge UK

6. Department of Internal Medicine Rio de Janeiro State University Rio de Janeiro Brazil

7. AstraZeneca Gothenburg Mölndal Sweden

8. Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

9. University of Groningen, University Medical Center Groningen the Netherlands

10. Department of Endocrinology and Metabolism Peking University People's Hospital Beijing China

11. AstraZeneca Madrid Spain

12. Department of Metabolic Medicine Center for Outcomes Research and Clinical Epidemiology Pescara Italy

13. AstraZeneca Luton UK

14. German Diabetes Center Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf Germany

15. Endocrinology Research Centre Diabetes Institute Moscow Russian Federation

16. Graduate School of Medicine Osaka University Osaka Japan

17. Saint Luke's Mid America Heart Institute Kansas City Missouri USA

18. Graduate School of Medicine Juntendo University Tokyo Japan

19. University of Missouri Kansas City Missouri USA

20. The George Institute for Global Health and University of New South Wales Sydney New South Wales Australia

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14401

Reference13 articles.

1. International Diabetes Federation.IDF Diabetes Atlas ninth edition 2019.https://www.diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf. Accessed May 15 2020.

2. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014

3. Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging

4. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)

5. United States Renal Data System.2018 USRDS annual data report: epidemiology of kidney disease in the United States.https://www.usrds.org/2018/view/Default.aspx. Accessed June 3 2020.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers to early diagnosis of chronic kidney disease and use of sodium‐glucose cotransporter‐2 inhibitors for renal protection: A comprehensive review and call to action;Diabetes, Obesity and Metabolism;2024-08-14

2. Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study;eClinicalMedicine;2024-06

3. Progression of chronic kidney disease among adults attending tertiary hospitals in Dodoma, Tanzania;2024-04-04

4. Prevalence of chronic kidney disease in Tunisian diabetics: the TUN-CKDD survey;BMC Nephrology;2024-02-25

5. Direct Medical Costs and Medication Use Trends in Patients Having Type 2 Diabetes with Chronic Kidney Disease in Beijing, China in 2016–2018;2024-02-13